IL-8 producing cells in patients with Behçet's disease
- PMID: 10812500
IL-8 producing cells in patients with Behçet's disease
Abstract
Objective: IL-8 is thought to be the principal chemokine responsible for neutrophil activation and tissue infiltration in patients with Behçet's disease (BD). In various studies serum levels of IL-8 were reported to be increased.
Methods: IL-8 mRNA was purified from both peripheral whole blood samples and separated lymphocytes, granulocytes and monocytes of patients with BD and compared to that from healthy (HC) and disease controls. IL-8 sequences were revealed by PCR amplification using appropriate sequence-specific primers. mRNA levels were determined semi-quantitatively using an image analyser in comparison with beta-actin.
Results: Although the differences did not reach statistical significance, BD patients tended to have higher IL-8 mRNA levels compared to HC in whole blood samples (2.0 +/- 1.4 vs 1.5 +/- 1.2) as well as in their lymphocytes (2.7 +/- 1.6 vs 1.5 +/- 0.9). No differences were observed between BD and HC in monocyte or granulocyte IL-8 mRNA levels.
Conclusion: Our results suggest that the cellular source of IL-8 is diverse in BD with a possible major contribution by lymphocytes.
Similar articles
-
Serum IL-33 levels and skin mRNA expression in Behçet's disease.Clin Exp Rheumatol. 2013 May-Jun;31(3 Suppl 77):6-14. Epub 2013 Mar 4. Clin Exp Rheumatol. 2013. PMID: 23464866
-
Plasma and whole-blood chemokine levels in patients with Behcet's disease.Graefes Arch Clin Exp Ophthalmol. 2003 May;241(5):353-8. doi: 10.1007/s00417-003-0668-y. Epub 2003 Apr 23. Graefes Arch Clin Exp Ophthalmol. 2003. PMID: 12712358
-
Synovial lymphoid neogenetic factors in Behçet's synovitis: do they play a role in self-limiting and subacute course of arthritis?Clin Exp Rheumatol. 2007 Jul-Aug;25(4 Suppl 45):S21-6. Clin Exp Rheumatol. 2007. PMID: 17949547
-
Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behçet's disease. A comparative study with familial Mediterranean fever and healthy subjects.J Rheumatol. 1993 Sep;20(9):1544-9. J Rheumatol. 1993. PMID: 8164212
-
Up-regulation of Th17 and related cytokines in Behçet's disease corresponding to disease activity.Clin Exp Rheumatol. 2013 May-Jun;31(3 Suppl 77):32-40. Epub 2013 Sep 9. Clin Exp Rheumatol. 2013. PMID: 24064012
Cited by
-
Saliva and Serum Cytokine Profiles During Oral Ulceration in Behçet's Disease.Front Immunol. 2021 Dec 22;12:724900. doi: 10.3389/fimmu.2021.724900. eCollection 2021. Front Immunol. 2021. PMID: 35003055 Free PMC article.
-
Immune and inflammatory gene expressions are different in Behçet's disease compared to those in Familial Mediterranean Fever.Eur J Rheumatol. 2016 Dec;3(4):146-152. doi: 10.5152/eurjrheum.2016.15099. Epub 2016 Dec 1. Eur J Rheumatol. 2016. PMID: 28149656 Free PMC article.
-
'MHC-I-opathy'-unified concept for spondyloarthritis and Behçet disease.Nat Rev Rheumatol. 2015 Dec;11(12):731-40. doi: 10.1038/nrrheum.2015.147. Epub 2015 Nov 3. Nat Rev Rheumatol. 2015. PMID: 26526644 Review.
-
Putative Role of Serum Amyloid-A and Proinflammatory Cytokines as Biomarkers for Behcet's Disease.Medicine (Baltimore). 2015 Oct;94(42):e1858. doi: 10.1097/MD.0000000000001858. Medicine (Baltimore). 2015. PMID: 26496336 Free PMC article.
-
Etanercept therapy in Behçet's disease. The tight control strategy in refractory disease.Z Rheumatol. 2014 Sep;73(7):650-6. doi: 10.1007/s00393-013-1307-6. Z Rheumatol. 2014. PMID: 24549921 Clinical Trial.